Magellan Health (MGLN) Misses Q1 EPS by 1c; Updates EPS Outlook

Magellan Health (NASDAQ: MGLN) reported Q1 EPS of $0.54, $0.01 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.04 billion.

GUIDANCE:

Magellan Health sees FY2016 EPS of $3.19-$3.96, versus the consensus of $2.74.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c